CIK 0001408443 · Non-accelerated filer<br>Smaller reporting company
Milestone Pharmaceuticals Inc.
Sign in to watch- Ticker
- MIST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Quebec, Canada
- Entity type
- operating
- Phone
- (514) 336-0444
- Business address
- 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420, MONTREAL, Quebec, Canada, H4M 2X6
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 32 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-11 | Hasija Amit CFO & EVP of Corp. Development | Grant or award · Series A Common Warrants (right to buy) | +50,000 | 50,000 | ||
| 2025-07-11 | Hasija Amit CFO & EVP of Corp. Development | Grant or award · Series B Common Warrants (right to buy) | +50,000 | 50,000 | ||
| 2025-07-11 | Wills Robert James Director | Grant or award | +50,000 | 65,000 | ||
| 2025-07-11 | Wills Robert James Director | Grant or award · Series A Common Warrants (right to buy) | +50,000 | 50,000 | ||
| 2025-07-11 | Wills Robert James Director | Grant or award · Series B Common Warrants (right to buy) | +50,000 | 50,000 | ||
| 2025-07-11 | Bharucha David Chief Medical Officer | Grant or award | +53,333 | 63,333 | ||
| 2025-07-11 | Bharucha David Chief Medical Officer | Grant or award · Series A Common Warrants (right to buy) | +53,333 | 53,333 | ||
| 2025-07-11 | Bharucha David Chief Medical Officer | Grant or award · Series B Common Warrants (right to buy) | +53,333 | 53,333 | ||
| 2025-07-11 | Oliveto Joseph President and CEO | Grant or award | +66,666 | 347,221 | ||
| 2025-07-11 | Oliveto Joseph President and CEO | Grant or award · Series A Common Warrants (right to buy) | +66,666 | 66,666 | ||
| 2025-07-11 | Oliveto Joseph President and CEO | Grant or award · Series B Common Warrants (right to buy) | +66,666 | 66,666 | ||
| 2025-07-11 | Muller Lorenz Chief Commercial Officer | Grant or award | +66,666 | 175,052 | ||
| 2025-07-11 | Muller Lorenz Chief Commercial Officer | Grant or award · Series A Common Warrants (right to buy) | +66,666 | 66,666 | ||
| 2025-07-11 | Muller Lorenz Chief Commercial Officer | Grant or award · Series B Common Warrants (right to buy) | +66,666 | 66,666 | ||
| 2025-07-11 | PAPA JOSEPH C Director | Grant or award | +100,000 | 100,000 | ||
| 2025-07-11 | PAPA JOSEPH C Director | Grant or award · Series A Common Warrants (right to buy) | +100,000 | 100,000 | ||
| 2025-07-11 | PAPA JOSEPH C Director | Grant or award · Series B Common Warrants (right to buy) | +100,000 | 100,000 | ||
| 2025-06-10 | Wills Robert James Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2025-06-10 | TOMSICEK MICHAEL JOHN Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2025-06-10 | Saik Andrew Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 |
Page 4 of 9 · 163 trades